Loading...
Loading...
Browse all stories on DeepNewz
VisitJAMA Study Links Bayer and AbbVie's Hormonal IUDs to Increased Breast Cancer Risk
Oct 16, 2024, 04:00 PM
A recent cohort study published in JAMA on Monday has found an association between the use of levonorgestrel-releasing intrauterine systems (IUDs) and an increased risk of breast cancer in females aged 15 to 49 years. The study indicates that while the risk remains low overall, it is higher compared to nonuse. Bayer, a dominant player in the hormonal IUD market with products such as Kyleena, Mirena, and Skyla, could be significantly impacted by these findings. AbbVie, which produces the IUD Liletta, is also mentioned in the context of this research. This study raises concerns about the safety of hormonal birth control devices used by millions of women worldwide.
View original story
Increase by more than 20% • 25%
Increase by 10% to 20% • 25%
Increase by less than 10% • 25%
Decrease • 25%
Yes • 50%
No • 50%
Decrease by more than 10% • 25%
No significant change (within 10%) • 25%
Increase by 10-20% • 25%
Increase by more than 20% • 25%
Yes • 50%
No • 50%
Increase by 10% or more • 25%
Increase by less than 10% • 25%
No significant change • 25%
Decrease • 25%
Stock price increases by more than 10% • 25%
Stock price increases by 5-10% • 25%
Stock price remains within +/- 5% • 25%
Stock price decreases by more than 5% • 25%
Increase by more than 5% • 25%
Increase by 0-5% • 25%
Decrease by 0-5% • 25%
Decrease by more than 5% • 25%
Decrease by up to 1% • 25%
Increase by 1% or more • 25%
Decrease by more than 1% • 25%
No significant change • 25%